Cerapedics

Nov 18, 2019

Cerapedics Announces FDA Approval of PMA Supplement Based on Two-Year Clinical Data

Jun 24, 2019

Cerapedics Appoints Patrick O'Connor as Vice President of Clinical and Market Development

Mar 06, 2019

Cerapedics Announces ISASS Bone Grafting Policy Statement Features i-FACTOR(TM) Peptide Enhanced Bone Graft

Jul 30, 2018

Cerapedics Announces First Patients Enrolled in IDE Clinical Trial of P-15L Bone Graft for Transforaminal Lumbar Interbody Fusion Surgery

Jul 13, 2018

Cerapedics Announces Closing of $22 Million Financing

Jun 13, 2018

Cerapedics Receives 2018 MedTech Breakthrough Award for Best New Surgical Technology Solution

May 21, 2018

Cerapedics Announces Presentation of Results from the IVANOS Study of i-FACTOR(TM) Peptide Enhanced Bone Graft in Uninstrumented Lumbar Posterolateral Spine Surgery

Oct 26, 2017

Cerapedics Announces i-FACTOR(TM) Peptide Enhanced Bone Graft Adopted by More than 150 Leading U.S. Hospitals

Oct 25, 2017

Cerapedics Announces Appointment of Doug Kohrs to Board of Directors and Names Antony Koblish Board Chair

Sep 12, 2017

Cerapedics Announces Publication of Two-Year IDE Study Follow-Up Data on i-FACTOR(TM) Bone Graft in the Cervical Spine